Concepedia

Shogo Okazaki

SO

Statistics

Publications

23

Citations

884

H-Index

17

Active since

2011

Affiliations

Keio University(Current)

Kindai University

Tokyo University of Science

Institute for Advanced Medical Research

Tohoku University

Shogo Okazaki is an author at Keio University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2011–2024

23

Publications

23

The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc( <b>—</b> )

Kenji Tsuchihashi, Shogo Okazaki, Mitsuyo Ohmura et al. · Cancer Research · 2016 · 114 citations · Full text

, , +17

Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy

M. Ohkawa, Yoshiya Ohno, Kazue Masuko et al. · Biochemical and Biophysical Research Communications · 2011 · 97 citations

, , +10

Glutaminolysis‐related genes determine sensitivity to xCT‐targeted therapy in head and neck squamous cell carcinoma

Shogo Okazaki, Kiyoko Umene, Juntaro Yamasaki et al. · Cancer Science · 2019 · 85 citations · Full text

, , +13

Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells

Shogo Okazaki, Subaru Shintani, Yuki Hirata et al. · Oncotarget · 2018 · 82 citations · Full text

, , +17

CD44 variant‐dependent redox status regulation in liver fluke‐associated cholangiocarcinoma: A target for cholangiocarcinoma treatment

Malinee Thanee, Watcharin Loilome, Anchalee Techasen et al. · Cancer Science · 2016 · 70 citations · Full text

, , +17

1–5 of 23